BrainBits, LLC

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

BrainBits, LLC - overview

Established

1999

Location

Springfield, IL, US

Primary Industry

Biotechnology

About

Founded in 1999 and based in Illinois, US, BrainBits, LLC operates as a biotechnology company that provides micro-surgically dissected live brain tissues to pharmaceutical, laboratory, and neurosciences researchers. In December 2019, YX Genomics Holding Corporation acquired BrainBits, LLC from MPG Equity Partners. Financial terms of the transaction were not disclosed. BrainBits, LLC offers an automated genotyping system for detecting transgenic, knockout, knock-in, SNP, and CRISPR mutations in animal research models.


and provides mouse and rat brain cells and other cells including microglia and cardiomyocyte cells for research. It also provides rat and mouse kits for cell development.


Current Investors

Thompson Street Capital Partners, Abacus Finance, YX Genomics Holding Corporation

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy

Website

www.brainbitsllc.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

BrainBits, LLC - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-on, Trade SaleCompletedBrainBits, LLC-
RecapitalisationCompletedBrainBits, LLC-
BuyoutCompletedBrainBits, LLC-

Displaying 1 - 3 of 3

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.